Implantation in IVF

International Surgery

Volumn 91, Issue 5 SUPPL., 2006, Pages

  Busso, Cristiano E ^a   Melo, Marco A B ^a   Fernandez, Manuel ^a   Pellicer, Antonio ^a,b   Simon, Carlos ^a,b,c  

^a INSTITUTO VALENCIANO DE INFERTILIDAD   (Spain)

^b Fundación IVI para el Estudio de la Reproducción   (Spain)

^c UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Early pregnancy loss; Implantation; Implantation failure; In vitro fertilization

Indexed keywords

CONGENITAL MALFORMATION; EMBRYO TRANSFER; ENDOMETRIUM; ENDOMETRIUM TUMOR; FEMALE; FERTILIZATION IN VITRO; HUMAN; MUELLERIAN DUCT; MYOMA; NIDATION; OVULATION INDUCTION; PATHOPHYSIOLOGY; PHYSIOLOGY; PREGNANCY; REVIEW; SPONTANEOUS ABORTION; TREATMENT OUTCOME;

ABORTION, SPONTANEOUS; EMBRYO IMPLANTATION; EMBRYO TRANSFER; ENDOMETRIAL NEOPLASMS; ENDOMETRIUM; FEMALE; FERTILIZATION IN VITRO; HUMANS; MULLERIAN DUCTS; MYOMA; OVULATION INDUCTION; PREGNANCY; TREATMENT OUTCOME;

EID: 33750186344     PISSN: 00208868     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (142)

1. Simon C, Gimeno MJ, Mercader A, Frances A, Garcia Velasco J, Remohi J et al. Cytokines-adhesion molecules-invasive proteinases: the missing paracrine/autocrine link in embryonic implantation? Mol Hum Reprod 1996;2:405-424
2. Simon C, Landeras J, Zuzuarregui JL, Martin JC, Remohi J, Pellicer A. Early pregnancy losses in in vitro fertilization and oocyte donation. Fertil Steril 1999;72:1061-1065
3. Alexander CM, Werb Z. Extracellular matrix degradation. In: Hay ED (ed). Cell Biology of Extracellular Matrix. New York: Plenum Press, 1991: 225-302
4. Matrisian LM. Metalloproteinases and their inhibitors in matrix remodeling. Trends Genet 1990;6:121-125
5. Tesarik J, Junca AM, Hazout A, Aubriot FX, Nathan C, Cohen-Bacrie P et al. Embryos with high implantation potential after intracytoplasmic sperm injection can be recognized by a simple, non-invasive examination of pronuclear morphology. Hum Reprod 2000;15:1396-1399
6. Wittemer C, Bettahar-Lebuge K, Ohl J, Rongieres C, Nisand I, Gerlinger P. Zygote evaluation: an efficient tool for embryo selection. Hum Reprod 2000;15:2591-2597
7. Balaban B, Urman B, Isiklar A, Alatas C, Aksoy S, Mercan R et al. The effect of pronuclear morphology on embryo parameters and blastocyst transfer outcome. Hum Reprod 2001;16:2357-2361
8. Zollner U, Zollner KP, Hartl G, Dietl J, Steck T. The use of a detailed zygote score after IVF/ICSI to obtain good quality blastocysts: the German experience. Hum Reprod 2001;17:1327-1333
9. Lundin K, Bergh C, Hardarson T. Early embryo cleavage is a strong indicador of embryo quality in human IVF. Hum Reprod 2001;16:2652-2657
10. Sakkas D, Percival G, Dárcy Y, Sharif K, Afnan M. Assessment of early cleaving in vitro fertilized human embryos at the 2-cell stage before transfer improves embryo selection. Fertil Steril 2001;76:1150-1156
11. Fenwick J, Plateau P, Murdoch AP, Herbert M. Time from insemination to first cleavage predicts developmental competence of human preimplantation embryos in vitro. Hum Reprod 2002;17:407-412
12. Desai N, Goldstein J, Rowland D, Goldfarb J. Morphological evaluation of human embryos and derivation of embryo quality scoring system specific for day 3 embryos: preliminary study. Hum Reprod 2000;15:2190-2196
13. Rienzi L, Ulbaldi F, Iacobelli M, Ferrero S, Minasi MG, Martinez F et al. Day 3 embryo transfer with combined evaluation at the pronuclear and cleavage stages compares favourably with day 5 blastocyst transfer. Hum Reprod 2002;17:1852-1855
14. Hardarson T, Hanson C, Sjögren A, Lundin K. Human embryos with unevenly sized blastomeres have lower pregnancy and implantation rates: indications for aneuploidy and multinucleation. Hum Reprod 2001;16:313-318
15. Alikani M, Calderon G, Tomkin G, Garrisi G, Kokot M, Cohen J. Cleavage anomalies in early human embryos and survival after prolonged culture in vitro. Hum Reprod 2000;15:2634-2643
16. Check J, Wilson C, Summers-Chase D, Choe J, Nazari A, Lurie D. Pregnancy rates according to embryo cell number at time of embryo transfer. Clin Exp Obstet Gynecol 2001;28:73-77
17. Gianaroli L, Plachot M, Magli MC. The atlas of embryology. Human Reprod 2000;15:1-79
18. Blake D, Proctor M, Johnson N, Olive D. Cleavage stage versus blastocyst stage transfer in assisted conception (Cochrane Review). Cochrane Database Syst Rev 2
19. Vidaeff AC, Racowsky C, Rayburn WF. Blastocyst transfer in human in vitro fertilization: a solution to the multiple pregnancy epidemic. J Reprod Med 2000;45:529-539
20. Kovacic B, Vlaisavljevic V, Reljic M, Gavric Lovrec V. Clinical outcome of day 2 versus day 5 transfer in cycles with one or two developed embryos. Fertil Steril 2002;77:529-536
21. Magli M, Jones G, Gras L, Gianaroli L, Korman I, Trounson A. Chromosome mosaicism in day 3 aneploid embryos that develop to morphologically normal blastocysts in vitro. Hum Reprod 2000;15:1781-1786
22. Van Blerkom J, Hanry G. oocyte dysmorphism and aneuploidy in meiotically-mature human oocytes after ovarian stimulation. Hum Reprod 1992;7:379-390
23. Munné S, Cohen J. Chromosome abnormalities in human embryos. Hum Reprod Update 1998;4:842-855
24. Gardner DK, Vella P, Lane M. Culture and transfer of blastocysts increases implantation rates and reduces the need for multiple embryo transfers. Fertil Steril 1998;69:84-88
25. Papanikolaou EG, Camus M, Kolibianakis EM, Van Landuyt L, Van Steirteghem A, Devroey P. In vitro fertilization with single blastocyst-stage versus single cleavage-stage embryos. N Engl J Med 2006;354:1190-1193
26. Lessey BA, Arnold JT. Paracrine signaling in the endometrium: integrins and the establishment of uterine receptivity. J Reprod Immunol 1998;39:105-116
27. Stewart CL. Leukaemia inhibitory factor and the regulation of pre-implantation development of the mammalian embryo. Mol Reprod Dev 1994;39:233-238
28. Stewart CL, Kaspar P, Brunet LJ, Bhatt H, Gadi I, Kontgen F et al. Blastocyst implantation depends on maternal expression of leukaemia inhibitory factor. Nature 1992;359:76-79
29. Charnock-Jones DS, Sharkey AM, Fenwick P, Smith SK. Leukaemia inhibitory factor mRNA concentration peaks in human endometrium at the time of implantation and the blastocyst contains mRNA for the receptor at this time. J Reprod Fertil 1994;101:421-426
30. Kojima K, Kanzaki H, Iwai M, Hatayama H, Fujimoto M, Inoue T et al. Expression of leukemia inhibitory factor in human endometrium and placenta. Biol Reprod 1994;50:882-887
31. Birdsall MA, Hopkisson JF, Grant KE, Barlow DH, Mardon HJ. Expression of heparin-binding epidermal growth factor messenger RNA in the human endometrium. Mol Hum Reprod 1996;2:31-34
32. Yoo HJ, Barlow DH, Mardon HJ. Temporal and spatial regulation of expression of heparin-binding epidermal growth factor-like growth factor in the human endometrium: a possible role in blastocyst implantation. Dev Genet 1997;21:102-108
33. Leach RE, Khalifa R, Ramirez ND, Das SK, Wang J, Dey SK et al. Multiple roles for heparin-binding epidermal growth factor-like growth factor are suggested by its cell-specific expression during the human endometrial cycle and early placentation. J Clin Endocrinol Metab 1999;84:3355-3363
34. Zhu LJ, Cullinan-Bove K, Polihronis M, Bagchi MK, Bagchi IC. Calcitonin is a progesterone-regulated marker that forecasts the receptive state of endometrium during implantation. Endocrinology 1998;139:3923-3934
35. Nikas G, Psychoyos A. Uterine pinopodes in peri-implantation human endometrium: clinical relevance. Ann N Y Acad Sci 1997;816:129-142
36. Check JH, Nowroozi K, Choe J, Dietterich C. Influence of endometrial thickness and echo patterns on pregnancy rates during in vitro fertilization. Fertil Steril 1991;56:1173-1175
37. Dickey RP, Olar TT, Curole DN, Taylor SN, Rye PH. Endometrial pattern and thickness associated with pregnancy outcome after assisted reproduction technologies. Hum Reprod 1992;7:418-421
38. Noyes N, Liu HC, Sultan K, Schattman G, Rosenwaks Z. Endometrial thickness appears to be a significant factor in embryo implantation in in-vitro fertilization. Hum Reprod 1995;10:919-922
39. Rinaldi L, Lisi F, Floccari A, Lisi R, Pepe G, Fishel S. Endometrial thickness as a predictor of pregnancy after in-vitro fertilization but not after intracytoplasmic sperm injection. Hum Reprod 1996;11:1538-1541
40. Yuval Y, Lipitz S, Dor J, Achiron R. The relationships between endometrial thickness, and blood flow and pregnancy rates in in-vitro fertilization. Hum Reprod 1999;14:1067-1071
41. De Geyter C, Schmitter M, De Geyter M, Nieschlag E, Holzgreve W, Schneider HP. Prospective evaluation of the ultrasound appearance of the endometrium in a cohort of 1,186 infertile women. Fertil Steril 2000;73:106-113
42. Bassil S. Changes in endometrial thickness, width, length and pattern in predicting pregnancy outcome during ovarian stimulation in in vitro fertilization. Ultrasound Obstet Gynecol 2001;18:258-263
43. Paulson RJ, Sauer MV, Lobo RA. Factors affecting embryo implantation after human in vitro fertilization: a hypothesis. Am J Obstet Gynecol 1990;163(6 Pt 1):2020-2023
44. Seif MW, Pearson JM, Ibrahim ZH, Buckley CH, Aplin JD, Buck P et al. Endometrium in in-vitro fertilization cycles: morphological and functional differentiation in the implantation phase. Hum Reprod 1992;7:6-11
45. Psychoyos A. Uterine receptivity for egg-implantation and scanning electron microscopy. Acta Eur Fertil 1993;24:41-42
46. Kolb BA, Paulson RJ. The luteal phase of cycles utilizing controlled ovarian hyperstimulation and the possible impact of this hyperstimulation on embryo implantation. Am J Obstet Gynecol 1997;176:1262-1267
47. Kolibianakis EM, Bourgain C, Platteau P, Albano C, Van Steirteghem AC, Devroey P. Abnormal endometrial development occurs during the luteal phase of nonsupplemented donor cycles treated with recombinant follicle-stimulating hormone and gonadotropin-releasing hormone antagonists. Fertil Steril 2003;80:464-466
48. Nikas G, Makrigiannakis A, Hovatta O, Jones HW Jr. Surface morphology of the human endometrium: basic and clinical aspects. Ann N Y Acad Sci 2000;900:316-324
49. Giudice LC. Elucidating endometrial function in the postgenomic era. Hum Reprod Update 2003;9:223-235
50. Develioglu OH, Hsiu JG, Nikas G, Toner JP, Oehninger S, Jones HW Jr. Endometrial estrogen and progesterone receptor and pinopode expression in stimulated cycles of oocyte donors. Fertil Steril 1999;71:1040-1047
51. Simon C, Mercader A, Frances A, Gimeno MJ, Polan ML, Remohi J et al. Hormonal regulation of serum and endometrial IL-1 alpha, IL-1 beta and IL-1ra: IL-1 endometrial microenvironment of the human embryo at the apposition phase under physiological and supraphysiological steroid level conditions. J Reprod Immunol 1996;31:165-184
52. Okada H, Nakajima T, Yoshimura T, Yasuda K, Kanzaki H. Microarray analysis of genes controlled by progesterone in human endometrial stromal cells in vitro. Gynecol Endocrinol 2003;17:271-280
53. Rossi M, Sharkey AM, Vigano P, Fiore G, Furlong R, Florio P et al. Identification of genes regulated by interleukin-1beta in human endometrial stromal cells. Reproduction 2005;130:721-729
54. White CA, Salamonsen LA. A guide to issues in microarray analysis: application to endometrial biology. Reproduction 2005;130:1-13
55. Krikun G, Schatz F, Taylor R, Critchley HO, Rogers PA, Huang J et al. Endometrial endothelial cell steroid receptor expression and steroid effects on gene expression. J Clin Endocrinol Metab 2005;90:1812-1818
56. Mirkin S, Nikas G, Hsiu JG, Diaz J, Oehninger S. Gene expression profiles and structural/functional features of the peri-implantation endometrium in natural and gonadotropin-stimulated cycles. J Clin Endocrinol Metab 2004;89:5742-5752
57. Horcajadas JA, Riesewijk A, Polman J, van Os R, Pellicer A, Mosselman S et al. Effect of controlled ovarian hyperstimulation in IVF on endometrial gene expression profiles. Mol Hum Reprod 2005;11:195-205
58. Simon C, Oberye J, Bellver J, Vidal C, Bosch E, Horcajadas JA et al. Similar endometrial development in oocyte donors treated with either high- or standard-dose GnRH antagonist compared to treatment with a GnRH agonist or in natural cycles. Hum Reprod 2005;20:3318-3327
59. Cohen J. Embryo replacement technology. San Francisco 31 Annual Postgraduate Course. ASRM, 1998.
60. Karande VC, Morris R, Chapman C, Rinehart J, Gleicher N. Impact of the "physician factor" on pregnancy rates in a large assisted reproductive technology program: do too many cooks spoil the broth? Fertil Steril 1999;71:1001-1009
61. Hearns-Stokes RM, Miller BT, Scott L, Creuss D, Chakraborty PK, Segars JH. Pregnancy rates after embryo transfer depend on the provider at embryo transfer. Fertil Steril 2000;74:80-86
62. Knutzen V, Stratton CJ, Sher G, McNamee PI, Huang TT, Soto-Albors C. Mock embryo transfer in early luteal phase, the cycle before in vitro fertilization and embryo transfer: a descriptive study. Fertil Steril 1992;57:156-162
63. Mansour R, Aboulghar M, Serour G. Dummy embryo transfer: a technique that minimizes the problems of embryo transfer and improves the pregnancy rate in human in vitro fertilization. Fertil Steril 1990;54:678-681
64. Sharif K, Afnan M, Lenton W. Mock embryo transfer with a full bladder immediately before the real transfer for in-vitro fertilization treatment: the Birmingham experience of 113 cases. Hum Reprod 1995;10:1715-1718
65. Mansour RT, Aboulghar MA, Serour GI, Amin YM. Dummy embryo transfer using methylene blue dye. Hum Reprod 1994;9:1257-1259
66. Nabi A, Awonuga A, Birch H, Barlow S, Stewart B. Multiple attempts at embryo transfer: does this affect in-vitro fertilization treatment outcome? Hum Reprod 1997;12:1188-1190
67. Coroleu B, Carreras O, Veiga A, Martell A, Martinez F, Belil I et al. Embryo transfer under ultrasound guidance improves pregnancy rates after in-vitro fertilization. Hum Reprod 2000;15:616-620
68. Lewin A, Schenker JG, Avrech O, Shapira S, Safran A, Friedler S. The role of uterine straightening by passive bladder distension before embryo transfer in IVF cycles. J Assist Reprod Genet 1997;14:32-34
69. Wisanto A, Janssens R, Deschacht J, Camus M, Devroey P, Van Steirteghem AC. Performance of different embryo transfer catheters in a human in vitro fertilization program. Fertil Steril 1989;52:79-84
70. Zeyneloglu HB, Arici A, Olive DL. Adverse effects of hydrosalpinx on pregnancy rates after in vitro fertilization-embryo transfer. Fertil Steril 1998;70:492-499
71. Camus E, Poncelet C, Goffinet F, Wainer B, Merlet F, Nisand I, Philippe HJ. Pregnancy rates after in-vitro fertilization in cases of tubal infertility with and without hydrosalpinx: a meta-analysis of published comparative studies. Hum Reprod 1999;14:1243-1249
72. Strandell A, Lindhard A. Why does hydrosalpinx reduce fertility?: the importance of hydrosalpinx fluid. Hum Reprod 2002;17:1141-1145
73. Strandell A. The influence of hydrosalpinx on IVF and embryo transfer: a review. Hum Reprod Update 2000;6:387-395
74. Conaghan J, Handyside AH, Winston RM, Leese HJ. Effects of pyruvate and glucose on the development of human preimplantation embryos in vitro. J Reprod Fertil 1993;99:87-95
75. Strandell A, Sjogren A, Bentin-Ley U, Thorburn J, Hamberger L, Brannstrom M. Hydrosalpinx fluid does not adversely affeet the normal development of human embryos and implantation in vitro. Hum Reprod 1998;13:2921-2925
76. Meyer WR, Castelbaum AJ, Somkuti S, Sagoskin AW, Doyle M, Harris JE et al. Hydrosalpinges adversely affect markers of endometrial receptivity. Hum Reprod 1997;12:1393-1398
77. Mansour RT, Aboulghar MA, Serour GI, Riad R. Fluid accumulation of the uterine cavity before embryo transfer: a possible hindrance for implantation. J Int Vitro Fert Embryo Transf 1991;8:157-159
78. Andersen AN, Lindhard A, Loft A, Ziebe S, Andersen CY. The infertile patient with hydrosalpinges-IVF with or without salpingectomy? Hum Reprod 1996;11:2081-2084
79. Bloechle M, Schreiner T, Lisse K. Recurrence of hydrosalpinges after transvaginal aspiration of tubal fluid in an IVF cycle with development of a serometra. Hum Reprod 1997;12:703-705
80. Eytan O, Azem F, Gull I, Wolman I, Elad D, Jaffa AJ. The mechanism of hydrosalpinx in embryo implantation. Hum Reprod 2001;16:2662-2667
81. Johnson NP, Mak W, Sowter MC. Surgical treatment for tubal disease in women due to undergo in vitro fertilisation. Cochrane Database Syst Rev 2004;3:CD002125
82. The Practice Comitte of the American Society for Reproductive Medicine. Salpingectomy for hydrosalpinx prior to in vitro fertilization. Fertil Steril 2004;82(Suppl 1):117-119
83. Green LK, Harris RE. Uterine anomalies: frequency of diagnosis and associated obstetric complications. Obstet Gynecol 1976;47:427-429
84. Heinonen PK, Pystynen PP. Primary infertility and uterine anomalies. Fertil Steril 1983;40:311-316
85. Golan A, Langer R, Bukovsky I, Caspi E. Congenital anomalies of the mullerian system. Fertil Steril 1989;51:747-755
86. Simon C, Martinez L, Pardo F, Tortajada M, Pellicer A. Mullerian defects in women with normal reproductive outcome. Fertil Steril 1991;56:1192-1193
87. Acien P. Incidence of Mullerian defects in fertile and infertile women. Hum Reprod 1997;12:1372-1376
88. Raga F, Bauset C, Remohi J, Bonilla-Musoles F, Simon C, Pellicer A. Reproductive impact of congenital Mullerian anomalies. Hum Reprod 1997;12:2277-2281
89. Acien P. Reproductive performance of women with uterine malformations. Hum Reprod 1993;8:122-126
90. Candiani GB, Fedele L, Parazzini F, Zamberletti D. Reproductive prognosis after abdominal metroplasty in bicornuate or septate uterus: a life table analysis. Br J Obstet Gynaecol 1990;97:613-617
91. Ayhan A, Yucel I, Tuncer ZS, Kisnisci HA. Reproductive performance after conventional metroplasty: an evaluation of 102 cases. Fertil Steril 1992;57:1194-1196
92. Helm P, Stampe Sorensen S. Pregnancy outcome after metroplasty in women with mullerian anomalies. Acta Obstet Gynecol Scand 1998;67:215-218
93. DeCherney AH, Russell JB, Graebe RA, Polan ML. Resectoscopic management of mullerian fusion defects. Fertil Steril 1986;45:726-728
94. Valle RF, Sciarra JJ. Hysteroscopic treatment of the septate uterus. Obstet Gynecol 1986;67:253-257
95. Choe JK, Baggish MS. Hysteroscopic treatment of septate uterus with Neodymium-YAG laser. Fertil Steril 1992;57:81-84
96. Donnez J, Jadoul P. What are the implications of myomas on fertility?: a need for a debate? Hum Reprod 2002;17:1424-1430
97. Hunt JE, Wallach EE. Uterine factors in infertility-an overview. Clin Obstet Gynecol 1974;17:44-64
98. Buttram VC Jr, Reiter RC. Uterine leiomyomata: etiology, symptomatology, and management. Fertil Steril 1981;36:433-445
99. Vollenhoven BJ, Lawrence AS, Healy DL. Uterine fibroids: a clinical review. Br J Obstet Gynaecol 1990;97:285-298
100. Wallach EE, Vu KK. Myomata uteri and infertility. Obstet Gynecol Clin North Am 1995;22:791-799
101. Bajekal N, Li TC. Fibroids, infertility and pregnancy wastage. Hum Reprod Update 2000;6:614-620
102. Stovall DW, Parrish SB, Van Voorhis BJ, Hahn SJ, Sparks AE, Syrop CH. Uterine leiomyomas reduce the efficacy of assisted reproduction cycles: results of a matched follow-up study. Hum Reprod 1998;13:192-197
103. Surrey ES, Minjarez DA, Stevens JM, Schoolcraft WB. Effect of myomectomy on the outcome of assisted reproductive technologies. Fertil Steril 2005;83:1473-1479
104. Van Bogaert LJ. Clinicopathologic findings in endometrial polyps. Obstet Gynecol 1988;71:771-773
105. Soares SR, Barbosa dos Reis MM, Camargos AF. Diagnostic accuracy of sonohysterography, transvaginal sonography, and hysterosalpingography in patients with uterine cavity diseases. Fertil Steril 2000;73:406-411
106. Preutthipan S, Linasmita V. A prospective comparative study between hysterosalpingography and hysteroscopy in the detection of intrauterine pathology in patients with infertility. J Obstet Gynaecol Res 2003;29:33-37
107. Brown SE, Coddington CC, Schnorr J, Toner JP, Gibbons W, Oehninger S. Evaluation of outpatient hysteroscopy, saline infusion hysterosonography, and hysterosalpingography in infertile women: a prospective, randomized study. Fertil Steril 2000;74:1029-1034
108. Fedele L, Molteni P, Zamberletti D, Grassi R, Vercellini P, Candiani GB. Hysteroscopy in the evaluation of infertile patients. Ann Ostet Ginecol Med Perinat 1983;104:165-188
109. Lass A, Williams G, Abusheikha N, Brinsden P. The effect of endometrial polyps on outcomes of in vitro fertilization (IVF) cycles. J Assist Reprod Genet 1999;16:410-415
110. Perez-Medina T, Bajo-Arenas J, Salazar F, Redondo T, Sanfrutos L, Alvarez P et al. Endometrial polyps and their implication in the pregnancy rates of patients undergoing intrauterine insemination: a prospective, randomized study. Hum Reprod 2005;20:1632-1635
111. Olivennes F. Results of IVF in women with endometriosis. J Gynecol Obstet Biol Reprod (Paris) 2003;32:S45-S47
112. Simón C, Gutierrez A, Vidal A, de los Santos MJ, Tarin JJ, Remohí J et al. Outcome of patients with endometriosis in assisted reproduction: results from in vitro fertilization and oocyte donation. Hum Reprod 1994;9:725-729
113. Lessey BA, Castelbaum SW, Sawin SW et al. Aberrant integrin expression in the endometrium of women with endometriosis. J Clin Endocrinol Metab 1994;79:643-649
114. Fedele L, Marchini M, Bianchi S, Dorta M, Arcaini L, Fontana PE. Structural and ultrastructural defects in preovulatory endometrium of normo-ovulating infertile women with minimal or mild endometriosis. Fertil Steril 1990;53:989-993
115. Garcia-Velasco J, Nikas G, Remohí J, Pellicer A, Simón C. Endometrial receptivity in terms of pinopode expression is not impaired in women with endometriosis in artificially prepared cycles. Fertil Steril 2001;6:1231-1233
116. Pellicer A, Oliveira N, Ruiz A, Remohi J, Simon C. Exploring the mechanism(s) of endometriosis-related infertility: An analysis of embryo development and implantation in assisted reproduction. Hum Reprod 1995;10(Suppl 2):91-97
117. Sung L, Mukherjee T, Takeshige T, Bustillo M, Copperman AB. Endometriosis is not detrimental to embryo implantation in oocyte recipients. J Assist Reprod Genet 1997;14:152-156
118. Díaz I, Navarro J, Blasco L, Simon C, Pellicer A, Remohi J. Impact of stage III-IV endometriosis on recipients of sibling oocytes: matched case-control study. Fertil Steril 2000;1:31-34
119. Prapas N, Prapas Y, Panagiotidis Y et al. Cervical dilatation has a positive impact on the outcome of IVF randomly assigned cases having two previous difficult embryo transfers. Hum Reprod 2004;19:1791-1795
120. Qublan HS, Eid SS, Ababneh HA, Amarin ZO, Smadi AZ, Al-Khafaji FF et al. Acquired and inherited thrombophilia: implication in recurrent IVF and embryo transfer failure. Hum Reprod (in press)
121. Fiedler K, Wurfel W. Effectivity of heparin in assisted reproduction. Eur J Med Res 2004;30:207-214
122. Prakash A, Ola B. Heparin/aspirin therapy for implantation failure in IVF cycles. Fertil Steril 2004;81:1431
123. Valbuena D, Martin J, de Pablo JL, Remohi J, Pellicer A, Simon C. Increasing levels of estradiol are deleterious to embryonic implantation because they directly affect the embryo. Fertil Steril 2001;76:962-968
124. Simon C, Dominguez F, Valbuena D, Pellicer A. The role of estrogen in uterine receptivity and blastocyst implantation. Trends Endocrinol Metab 2003;14:197-199
125. Lédée-Bataille N, Olivennes F, Kadoch J et al. Detectable levels of interleukin-18 in uterine lumial secretions at oocyte retrieval predict failure of the embryo transfer. Hum Reprod 2004;19:1968-1973
126. Tseng L, Mazella J. Prolactin and its receptor in human endometrium. Semin Reprod Endocrinol 1999;17:23-27
127. Hale L. Embryo transfer: how to ensure correct placement in utero. Reprod Fertil Dev 2001;13:95-98
128. Coroleu B, Barri PN, Carreras O, Martinez F, Parriego M, Hereter L et al. The influence of the depth of embryo replacement into the uterine cavity on implantation rates after IVF: a controlled, ultrasound-guided study. Hum Reprod 2002;17:341-346
129. Levitas E, Lunenfeld E, Har-Vardi I, Albotiano S, Sonin Y, Hackmon-Ram R et al. Blastocyst-stage embryo transfer in patients who failed to conceive in three or more day 2-3 embryo transfer cycles: a prospective, randomized study. Fertil Steril 2004;81:567-571
130. Simon C, Mercader A, Garcia-Velasco J, Nikas G, Moreno C, Remohi J et al. Coculture of human embryos with autologous human endometrial epithelial cells in patients with implantation failure. J Clin Endocrinol Metab 1999;84:2638-2646
131. Shapiro BS, Richter KS, Harris DC, Daneshmand ST. Dramatic declines in implantation and pregnancy rates in patients who undergo repeated cycles of in vitro fertilization with blastocyst transfer after one or more failed attempts. Fertil Steril 2001;76:538-542
132. De Vos A, Van Steirteghem A. Zona hardening, zona drilling and assisted hatching: new achievements in assisted reproduction. Cells Tissues Organs 2000;166:220-227
133. Rufas-Sapir O, Stein A, Orvieto R, Avrech OM, Kotler N, Bar J et al. Is assisted hatching beneficial in patients with recurrent implantation failures? Clin Exp Obstet Gynecol 2004;31:110-112
134. Germond M, Primi MP, Senn A. Hatching: how to select the clinical indications. Ann N Y Acad Sci 2004;1034:145-151
135. Edi-Osagie E, Hooper L, Seif MW. The impact of assisted hatching on live birth rates and outcomes of assisted conception: a systematic review. Hum Reprod 2003;18:1828-1835
136. Gianaroli L, Magli MC, Munne S, Fiorentino A, Montanaro N, Ferraretti AP. Will preimplantation genetic diagnosis assist patients with a poor prognosis to achieve pregnancy? Hum Reprod 1997;12:1762-1767
137. Munne S, Cohen J. Chromosome abnormalities in human embryos. Hum Reprod Update 1998;4:842-855
138. Pehlivan T, Rubio C, Rodrigo L, Romero J, Remohi J, Simon C et al. Impact of preimplantation genetic diagnosis on IVF outcome in implantation failure patients. Reprod Biomed Online 2003;6:232-237
139. Munné S, Sandalinas M, Escudero T, Marquez C, Cohen J. Chromosome mosaicism in cleavage-stage human embryos: evidence of a maternal age effect. Reprod Biomed Online 2002;4:223-232
140. Wang X, Chen C, Wang L, Chen D, Guang W, French J. Conception, early pregnancy loss, and time to clinical pregnancy: a population-based prospective study. Fertil Steril 2003;79:577-584
141. Liu HC, Rosenwaks Z. Early pregnancy wastage in IVF (in vitro fertilization) patients. J In Vitro Pert Embryo Transf 1991;8:65-72
142. Simon C, Landeras J, Zuzuarregui JL, Martin JC, Remohi J, Pellicer A. Early pregnancy losses in in vitro fertilization and oocyte donation. Fertil Steril 1999;72:1061-1065